Welcome!

News Feed Item

Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

http://www.reportlinker.com/p02170311/Global-Choroidal-Neovascularization-CNV-Market-2014-2018pdf.html

About CNVCNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the known causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently no medical treatment for this disease, this abnormal growth can easily lead to impairment of sight or complete loss of vision. TechNavio's analysts forecast the Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global CNV market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of CNV

TechNavio's report, the Global CNV Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global CNV market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• EMEA

• APAC

Key Vendors

• Bayer AG

• F. Hoffmann-La Roche Ltd.

• Novartis AG

• Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

• Affitech A/S• Allergan Inc.• Chengdu Kanghong Biotech Co. Ltd.• Gilead Sciences Inc.• Lpath Inc.• Mat Biopharma SAS• Pfizer Inc.• Promedior Inc.• QLT Inc.• Quark Pharmaceuticals Inc.• Resolvyx Pharmaceuticals Inc.• Sanwa Kagaku Kenkyusho Co. Ltd.• Valeant Pharmaceuticals International Inc.

Key Market Driver

• High Patient and Physician Satisfaction.

• For a full, detailed list, view our report.

Key Market Challenge

• High Cost of Treatment.

• For a full, detailed list, view our report.

Key Market Trend

• Strong Competition in the Market.

• For a full, detailed list, view our report.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

01. Executive Summary02. List of Abbreviations03. Scope of the Report03.1 Market Overview03.2 Product OfferingsProduct Profiles04. Market Research Methodology04.1 Market Research Process04.2 Research Methodology05. Introduction06. Market Landscape06.1 Market Overview06.2 Market Size and Forecast06.3 Five Forces Analysis07. Product Portfolio of Current CNV Therapies08. Clinical Pipeline Portpolio09. Rate of Incidence and Prevalence09.1.1 US10. Geographical Segmentation10.1 CNV Market in the Americas10.1.1 Market Size and Forecast10.2 CNV Market in the EMEA Region10.2.1 Market Size and Forecast10.3 CNV Market in the APAC Region10.3.1 Market Size and Forecast11. Buying Criteria12. Market Growth Drivers13. Drivers and their Impact14. Market Challenges15. Impact of Drivers and Challenges16. Market Trends17. Trends and their Impact18. Vendor Landscape18.1 Competitive Scenario18.1.1 Key News18.1.2 Mergers and Acquisitions18.2 Market Share Analysis 201318.3 Other Prominent Vendors18.4 Future Vendors to Tap the CNV Market19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global CNV Market 2013-2018 (US$ million)

Exhibit 3: Global CNV Market by Geographical Segmentation 2013

Exhibit 4: CNV Market in the Americas 2013-2018 (US$ million)

Exhibit 5: CNV Market in the EMEA Region 2013-2018 (US$ million)

Exhibit 6: CNV Market in the APAC Region 2013-2018 (US$ million)

Exhibit 7: Product-wise Revenue Share in Global CNV Market 2013 (in Percentage)

To order this report: Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf http://www.reportlinker.com/p02170311/Global-Choroidal-Neovascularization-CNV-Market-2014-2018pdf.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"NetApp's vision is how we help organizations manage data - delivering the right data in the right place, in the right time, to the people who need it, and doing it agnostic to what the platform is," explained Josh Atwell, Developer Advocate for NetApp, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that SourceForge has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. SourceForge is the largest, most trusted destination for Open Source Software development, collaboration, discovery and download on the web serving over 32 million viewers, 150 million downloads and over 460,000 active development projects each and every month.
What You Need to Know You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technolog...
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
SYS-CON Events announced today that Nihon Micron will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Nihon Micron Co., Ltd. strives for technological innovation to establish high-density, high-precision processing technology for providing printed circuit board and metal mount RFID tags used for communication devices. For more inf...
SYS-CON Events announced today that Ryobi Systems will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Ryobi Systems Co., Ltd., as an information service company, specialized in business support for local governments and medical industry. We are challenging to achive the precision farming with AI. For more information, visit http:...
SYS-CON Events announced today that mruby Forum will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. mruby is the lightweight implementation of the Ruby language. We introduce mruby and the mruby IoT framework that enhances development productivity. For more information, visit http://forum.mruby.org/.
SYS-CON Events announced today that Mobile Create USA will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Mobile Create USA Inc. is an MVNO-based business model that uses portable communication devices and cellular-based infrastructure in the development, sales, operation and mobile communications systems incorporating GPS capabi...
SYS-CON Events announced today that Daiya Industry will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Daiya Industry specializes in orthotic support systems and assistive devices with pneumatic artificial muscles in order to contribute to an extended healthy life expectancy. For more information, please visit https://www.daiyak...
SYS-CON Events announced today that Fusic will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Fusic Co. provides mocks as virtual IoT devices. You can customize mocks, and get any amount of data at any time in your test. For more information, visit https://fusic.co.jp/english/.
SYS-CON Events announced today that Keisoku Research Consultant Co. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Keisoku Research Consultant, Co. offers research and consulting in a wide range of civil engineering-related fields from information construction to preservation of cultural properties. For more information, vi...
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.
SYS-CON Events announced today that Interface Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Interface Corporation is a company developing, manufacturing and marketing high quality and wide variety of industrial computers and interface modules such as PCIs and PCI express. For more information, visit http://www.i...
Today companies are looking to achieve cloud-first digital agility to reduce time-to-market, optimize utilization of resources, and rapidly deliver disruptive business solutions. However, leveraging the benefits of cloud deployments can be complicated for companies with extensive legacy computing environments. In his session at 21st Cloud Expo, Craig Sproule, founder and CEO of Metavine, will outline the challenges enterprises face in migrating legacy solutions to the cloud. He will also prese...